reSee.it - Related Video Feed

The financial interests of the psychiatric and drug industries are intertwined, as the psychiatric industry identifies new disorders that can be treated with psychiatric drugs. These drugs are widely consumed in America, with one in five people taking psychoactive drugs. However, these drugs have adverse effects, including an increased risk of suicide and violence. It is concerning that a majority of school shooters have been on psychiatric drugs, which the FDA acknowledges increase the risk of such behavior. When investigating the cause of these incidents, the release of relevant information is often denied, supposedly to protect privacy interests. However, this argument is flawed, as the public has a right to access information and make informed decisions about their own well-being. The suppression of information and censorship may be driven by the financial interests of the psychiatric and drug industries.

The speaker discusses an asserted link between COVID-19 injections and neuropsychiatric disorders, claiming a strong association. They state that the information comes directly from the FDA and the CDC and promise to leave the study link in the comments. The speaker notes that “these were the thresholds that were all breached for being way over,” and asserts that the items about to be listed are “a more likely determination.” The claim is that these are thresholds or criteria related to the studied association, and the speaker emphasizes that these are “times” of likelihood. Specifically, the speaker lists several neuropsychiatric outcomes and how much more likely they are purported to be following vaccination. They say: psychosis is “four forty times more likely.” Dementia is “140 times” more likely. Schizophrenia is “three fifteen times” more likely. They also mention “Suicidal thoughts,” but the transcript ends before the figure for suicidal thoughts is provided. The speaker frames these figures as a direct consequence of the injections, tying them to the referenced thresholds and thresholds being breached as evidence of a strong association. In summary, the primary claims presented are that there exists a strong association between COVID-19 injections and neuropsychiatric disorders, supported by data from the FDA and CDC, with specific numerical claims that psychosis, dementia, and schizophrenia are markedly more likely post-injection, quantified as 440 times, 140 times, and 315 times more likely, respectively, with a forthcoming figure for suicidal thoughts that is not included in the provided transcript. The overall argument hinges on breached thresholds and the designation of these conditions as more likely determinations following vaccination, as presented by the speaker.

Fifteen percent of high schoolers are on Adderall, which was created by Merck in Nazi Germany to make German soldiers more aggressive. The drug was discontinued due to psychosis among soldiers, but Merck reformulated it into a stronger version, which is now Adderall. Parents are being pressured to put their kids on Adderall, just as they are with Ozempic, SSRIs, and SANs. Children in sedentary environments with limited sunlight, being fed ultra-processed food, are prescribed Adderall for being fidgety. This is mass child abuse, and it is being normalized.

Dr. Josef Duhring and Dr. Yosef (Doctor Yosef Duhring) discuss antidepressants and SSRIs, outlining perceived risks, data limitations, and long-term concerns, followed by practical guidance on tapering and contact information for a tapering clinic. Key side effects and risks cited - Common side effects: gastrointestinal issues (nausea, vomiting, diarrhea), changes in sleep (insomnia or drowsiness), headaches, nervousness, restlessness, dry mouth, sweating, tremors, sexual dysfunction, decreased libido, difficulty reaching orgasm, erectile dysfunction, appetite and weight changes (gain or loss). - Other reported effects: emotional blunting, feeling less like yourself, dizziness, balance issues (especially early in treatment), increased sweating, abnormal dreams. - Serious but rarer risks: suicidal thoughts or behaviors, particularly under age 25; serotonin syndrome (described as rare); heart rhythm changes at high doses with some SSRIs. - Behavioral effects: mania, psychosis, irritability, aggression; rare but potentially misdiagnosed as bipolar disorder; in some cases leading to escalation to lithium or antipsychotics. - Sleep and long-term effects: SSRI use diminishing sleep quality (less REM and deep sleep), resulting in fatigue and brain fog in long-term users. - Long-term data gaps: “there has never been a randomized control study that looked at them for over a year,” and “seventy percent of antidepressant users are on these drugs for two years or more.” Claims that there is no long-term data on sustained efficacy or safety beyond eight to twelve weeks. Efficacy and data concerns - Most drugs reach market based on eight-week studies; there is a reported two-point difference on a 52-point depression scale between the drug and placebo, which is described as clinically very low. - Outcomes most meaningful to patients (employment, relationships, life meaning) are not directly measured in standard trials, which focus on scale-based movement. - The claim is made that long-term efficacy remains unproven and that the long-term data are unavailable. Observations about prescription patterns and systemic factors - Online “pill mill” platforms allegedly enable easy access to SSRIs (Lexapro), sometimes without video chats, via online questionnaires, with rapid mail delivery. - The dose of prescription and patient interactions are affected by time constraints and economic incentives in healthcare delivery, leading to faster checklists and medication-based treatments rather than in-depth discussions of life context, relationships, or non-drug approaches. - An “unholy alliance” between the pharmaceutical industry and academic medicine is described: investigators may pursue drug trials for career advancement and publications funded by drug companies, potentially biasing conclusions in favor of medications. - The FDA’s stance is portrayed as influenced by this environment, with concerns about regulatory capture and inadequate critical evaluation of risks, including suicide risk data and withdrawal issues. Key long-term and withdrawal considerations - Long-term withdrawal: physicians are described as telling patients that antidepressant withdrawal is mild and resolves in two weeks, but tapering often requires one to two years to avoid withdrawal symptoms; many are tapered too quickly, leading to relapse or withdrawal challenges. - Tapers and recovery: the clinician reports patients improving emotionally during tapering, sometimes even before complete discontinuation; success depends on broader life health improvements (physical health, relationships, purpose) and careful, gradual reduction. Three major concerns observed with antidepressants (as described by Dr. Yosef) - They don’t work for many patients in the long term; diminished efficacy over time due to emotional blunting and neurochemical adaptation. - Behavioral and cognitive changes: potential for mania, psychosis, irritability, and misdiagnosis as bipolar disorder; risk of “drug-induced” psychiatric symptoms. - Toxicity and sleep: long-term blunting reduces emotional responsiveness; chronic sleep disruption and brain fog; long-term toxicity may underlie persistent symptoms after prolonged use. Clinical implications and guidance offered - For those considering antidepressants, emotions matter and should be explored beyond a chemical-imbalance narrative; discuss physical health, relationships, purpose, substances, and non-drug approaches (therapy, lifestyle changes) before relying on medication. - For those already on SSRIs, a careful, patient-guided taper is advised: slowly reduce dosages, use approaches such as liquid tapering to control precise reductions, and listen to one’s body to avoid withdrawal; a two-year taper may be necessary for many patients. - Coming off antidepressants can reveal or restore aspects of life and personality; benefits may appear during tapering as engagement and motivation return, but life circumstances must be addressed in parallel to avoid relapse. Contact information - Tapering clinic website: taperclinic.com (for patients in the U.S.; clinic claims to operate in about 15–16 states, covering roughly 70% of the population). - YouTube channel for further resources: Doctor Yosef (German version) with a free drug tapering training (about five hours) and guidance for working with a doctor. Speaker names - Dr. Yosef Duhring (referred to as Doctor Josef Duhring in the discussion) and Dr. Yosef (the same speaker) are cited; their experiences include FDA and industry roles and a tapering clinic specializing in antidepressant withdrawal and discontinuation.

The psychiatric and drug industries have a financial interest in each other's success. Psychiatric drugs are widely consumed in America, with one in five people taking psychoactive drugs. These drugs have adverse effects, including an increased risk of suicide and violence. Despite this, there is little outrage in the government and medical community about the connection between psychiatric drugs and school shootings. When investigating the cause of these shootings, the coroner's office refused to release information about the drugs involved, citing privacy concerns. However, the argument that withholding this information protects public health is unfounded. It is likely that the suppression of information is driven by the financial interests of the psychiatric and drug industries.

SSRIs are widely used: "About fourteen percent of the population" and "probably between fifteen to twenty percent" after COVID. Despite this, "There's more suicides" and "the outcomes are actually getting worse." Prozac "changed history" by "modulating the serotonin system" through "blocking serotonin reuptake" and making people "numb or emotionally constricted." The "chemical imbalance" story was a story "sold to doctors and patients" to justify drugs; "No brain scans, no blood tests" and used in diagnosis. The FDA is "funded by the pharmaceutical industry through PDUFA" with "70% funding," prioritizing drug development over safety signals. The "PSSD" stands for "post SSRI sexual dysfunction" and is experienced by "70 percent" with "permanent sexual dysfunction," "genital anesthesia," "cognitive damage," "emotional blunting" and "the suicide rate in this population is through the roof." There are withdrawal risks with benzodiazepines and "protracted withdrawal" can cause "brain injury."

School and mass shootings are unacceptable and require investigation, specifically into why they occur in the U.S. and why they didn't happen previously. SSRIs, psychiatric drugs with potential homicidal and suicidal side effects, should be investigated as a possible culprit due to their widespread use. The NIH should study why the U.S. experiences mass shootings so frequently compared to countries like Switzerland, which has comparable gun ownership. The speaker notes that children previously brought rifles to school without causing harm, highlighting the unique nature of the current issue. The speaker intends to change the NIH policy that has prevented the study of the origins of gun violence since 1996.

"About fourteen percent of the population" "Of the total population is currently taking an antidepressant medication." "Currently, yes." "it's probably between fifteen percent to twenty percent of the population." "That's I mean, compared to my childhood or even twenty five years ago, that's a massive increase." "It's an enormous increase. It's likely, you know, last statistics I looked at, I think it's about a 500% increase from where things were in in the nineties, in the early nineties." "No. There's actually more suicides. There's more disability from mental health problems, and teen suicide is higher as well." "What we're doing is not working on a national level." "I'm just gonna skip ahead to my opinion, then I'm gonna pull back. But that suggests that we should ban the drugs and imprison the people selling them."

In the last 52 years of documented school shootings in America committed by teenagers, 100% of them were on either an antidepressant or a barbiturate drug for anxiety. These drugs, like Prozac, Zoloft, and Xanax, are all published to increase the risk of suicide, violent behavior, and homicidal actions. For the last 52 years that we have been tracking and studying them, 100% of all school shooters were on drugs prescribed by medical doctors and brought to you by pharmacies like CVS and Walgreens.

Speaker 0 states that in the last fifty-two years of documented school shootings in America conducted by teenagers, a hundred percent were on either an antidepressant or a barbiturate drug for anxiety. They mention specific drugs such as Prozac, Zoloft, and Xanax, and claim that every one of these antidepressants and anti-anxiety drugs is published to increase the risk of suicide behavior/actions and to lead to violent and homicidal actions. They conclude that a hundred percent of all shooters were on drugs that are prescribed by medical doctors.

Do you believe antidepressants cause school shootings? That’s a complex question, and I didn’t provide a definitive answer. I mentioned that it should be studied alongside other factors, like social media. However, I can’t claim a direct link because there’s no conclusive science on this matter. There is research available, but it’s not definitive.

There is a lot of corruption in politics due to money, bribes, and backdoor deals. One major mistake was allowing drug companies to advertise on television, which only two countries, the United States and New Zealand, permit. These commercials often make exaggerated claims and list potential side effects very quickly. It's concerning how they can make something seem great one moment and then mention serious side effects like suicidal thoughts and rectal bleeding. Personally, I haven't taken many medications, but when I tried SSRIs, I found the last 20 seconds of the commercial more impactful than the rest, and I didn't experience any benefits from them.

Speaker 0 states that over 52 years of documented school shootings in America, a hundred percent of the shooters were teenagers on either an antidepressant or a barbiturate drug for anxiety. He claims that every antidepressant, including Prozac, Zoloft, Xanax, and all these antianxiety drugs and antidepressants, is published to increase the risk of suicide behavior actions and lead to violent and homicidal actions. He also asserts that a hundred percent of all shooters, across the documented history, were on drugs prescribed by their medical doctors, brought to you by CVS and Walgreens and others.

Since age 4, I've been on meds like Lexapro and Abilify that made me feel like a zombie. Foster care kids in the US are given powerful mind-altering drugs at a rate 13 times higher than other children. A GAO report reveals infants in foster care are given psychotropic drugs with unknown long-term effects. One case involved a 7-year-old on 5 risky medications. Foster parents are pressured to medicate or risk losing their child. The system profits from drugging vulnerable kids with expensive drugs.

The psychiatric and drug industries have a financial interest in each other's success. Psychiatric drugs are widely consumed in America, with 1 in 5 people using psychoactive drugs. However, these drugs have adverse effects, including an increased risk of suicide and violence. It is concerning that many school shooters have been on psychiatric drugs, which the FDA acknowledges can lead to such behaviors. When investigating the cause of these incidents, the coroner's office refused to release relevant information, citing privacy concerns. The assistant attorney general argued that disclosing this information could discourage people from taking their psychiatric medication, but this argument is flawed. The financial interests of the psychiatric and drug industries may be influencing the suppression of information and censorship. It is crucial to reconsider the use of these drugs, especially for children.

According to the speaker, 100% of documented school shootings in America over the past 52 years were committed by teenagers on either an antidepressant or a barbiturate drug for anxiety. The speaker claims that every antidepressant, including Prozac, Zoloft, and Xanax, as well as anti-anxiety drugs, are published to increase the risk of suicide, violent behavior, and homicidal actions. The speaker asserts that these drugs are prescribed by doctors and sold at pharmacies like CVS and Walgreens.

In 1955, there were 565,000 mentally ill people in state and county mental hospitals, with a disability rate of 141 in every 470 people. By 1987, when Prozac was introduced, the number of people on disability due to mental illness had increased to 1,250,000, with a disability rate of 1 in every 184. Since then, the United States has seen a significant rise in psychiatric medication sales, spending over $40 billion annually. The number of people on government disability due to mental illness has tripled to 4 million, with 850 adults being added daily. Additionally, the number of children receiving payments for mental disorders has increased from 16,200 to 600,000, with 250 children per day joining the disability program. This raises questions about whether the drug-based paradigm of care is contributing to this epidemic.

RFK is under fire for linking SSRIs to mass shootings and questioning chemicals in the water. A senator confronted him about blaming school shootings on antidepressants. RFK responded that he didn't definitively blame the shootings on the drugs, but that the connection should be studied alongside other potential causes like social media. The senator claimed studies disprove any link between antidepressants and school shootings, but RFK countered that HIPAA rules obscure the data. It's well known that SSRIs can cause homicidal thoughts, especially when brain chemistry is altered. If RFK blamed video games, it would be taken seriously, but questioning pharmaceuticals is controversial because it threatens the pharmaceutical industry. Infowars is facing financial hardship because people believe a Bloomberg gun control group owns it, which hurts sales. If Infowars doesn't get funds in at Infowars store, we will shut down. Many products are available now at infowarsstore.com including Brain Force Ultra, and Vasoveat.

Have you noticed your vaccinated friends or family have a different personality or are more angry since getting the injections? Well, there is a strong association between COVID-nineteen injections and neuropsychiatric disorders. This comes directly from the FDA and the CDC, and I'm gonna leave the link to the study in the comments, of course, but these were the thresholds that were all breached for being way over. And so you'll see that all these things I'm about to list off are a more likely determination. So these are times as well. So psychosis, four forty times more likely. Dementia, 140 times. Schizophrenia, three fifteen times. Suicidal thoughts,

I certainly consider mass shootings a health crisis and we are doing for the first time real studies to find out what the ideology of that is. And we're looking for the first time at psychiatric drugs. People have had guns in this country forever. There are many other countries that have comparable levels of guns that we have in this country. We had comparable levels in the forties, fifties, and sixties and people weren't doing that. Something changed and it dramatically changed human behavior. And one of the culprits we need to examine is whether the fact that we are the most over medicated nation in the world. And a lot of those are psychiatric drugs that have black box warnings on them that warn of suicidal and homicidal ideation. So we are doing those studies right now for the first time and we will have an answer.

Depression drugs cannot cure people, but they can influence certain symptoms like emotional numbness and reduced self-care. However, these drugs can also cause sexual dysfunction even after discontinuation. Overall, these drugs are deemed terrible and should not be used. Psychiatry is unique in the healthcare field as its leaders consistently lie about the capabilities of their drugs. This situation is disheartening.

Tucker Carlson interviews Dr. Daniel Amen about cannabis, brain health, and broader public health trends. Amen cites his 1000-person marijuana study showing lower brain blood flow and activity across all examined regions in users compared with healthy controls, with measurable deficits on SPECT imaging that assess blood flow and mitochondrial function. He explains mitochondria as cellular energy producers and notes that 49% of the tracer in their imaging is taken up by brain mitochondria; thus, low activity on the scan reflects reduced mitochondrial function and blood flow. He also references a separate study from an independent group of 1000 young marijuana users showing reduced blood flow and activity in brain areas involved in learning and memory, aligning with his assertion that marijuana is not innocuous for the brain. Amen lists consequences associated with reduced mitochondrial activity and blood flow: tiredness, low motivation, depression, increased anxiety (due to brain not settling), and, in vulnerable individuals, an increased risk of psychosis. He emphasizes that the connection between heavy marijuana use and psychosis is real and notes a genetic factor: a certain gene abnormality can lead to a sevenfold increase in the risk of psychosis in heavy users, with the general risk estimated at two to four times higher, particularly when use begins in youth. He argues that younger users face more brain development disruption and cites CDC data showing alarming mental-health trends among teens, including 57% of teenage girls reporting persistent sadness, 32% having thought of suicide, 24% having planned to kill themselves, and 13% having attempted it. He suggests marijuana contributes to this “mental mess,” though he acknowledges multiple factors. Carlson pushes back on the view of cannabis as a medicine, prompting Amen to discuss how, while cannabis can help certain conditions (glaucoma, appetite stimulation), it is not universally beneficial and can increase anxiety in some users. Amen describes a “doom loop” in which pain and distress trigger automatic negative thoughts (ANTs), amplifying suffering and potentially leading to relapse or worse mental health outcomes. He argues that cannabis can blunt certain pain pathways but, when used chronically, reinforces dependence and prevents brain rehabilitation. Amen contrasts marijuana with alcohol, describing rumors of “alcohol as health food” as a societal lie, noting recent statements by the American Cancer Society against any alcohol use due to cancer risk. He recounts experiences in psychiatry since the 1980s involving changes in attitudes toward gaming, alcohol, and drug policy, arguing that stimulants and sedatives (opiates, benzodiazepines) have historically created poor outcomes. He claims marijuana industry marketing aims to minimize perceived risk and accuses the industry of funding campaigns to mislead the public, similar to tactics used by historical industry players. In discussing brain imaging, Amen highlights the cerebellum (the “little brain”) as crucial for both movement and cognitive processing. Marijuana’s effect on the cerebellum can slow thinking and impair coordination, which underpins the admonition not to drive high. He explains that cannabis acts on CB1 receptors and modulates dopamine, producing a high but potentially disrupting dopamine in vulnerable individuals, sometimes triggering psychosis. Amen stresses the need to love and protect the brain, arguing that brain health should be prioritized in public policy. He advocates for preventing brain injury, reducing toxin exposure, maintaining sleep, exercise, and a healthy diet, and he introduces the Bright Minds framework: B = Blood flow; R = Retirement and aging (learn new things); I = Inflammation; G = Genetics; H = Head trauma; T = Toxins; M = Materials (personal products); I = Immunity; N = Neurohormones; D = Diabetes; S = Sleep. He explains how each factor affects brain health and how marijuana and obesity harm the brain by decreasing blood flow and increasing inflammation. He cites a study from the University of Pittsburgh showing overweight individuals have smaller brain volumes and older-appearing brains; obese individuals show even greater reductions. He notes that marijuana use lowers testosterone and can contribute to vascular problems, including a reported 600% increased heart attack risk for those over 50 who use marijuana. On ADHD and youth, Amen describes using brain scans to differentiate toxic brains from those with genuine ADHD, emphasizing that stimulants are not the universal answer and that underlying toxicities must be addressed. He recounts a case where a child’s left temporal lobe cyst caused behavioral changes, which surgery ultimately improved after imaging revealed the physical cause. He argues for looking at brain pathology before labeling and treating, and he describes his broader mission to foster a national brain health revolution, encouraging people to ask whether their actions are good for their brain. Amen also discusses psilocybin, kratom, and other substances, acknowledging potential therapeutic uses in specific contexts (psilocybin for PTSD/depression) while warning about risks such as unbalancing effects and the lack of standardized dosing in many studies. He notes a rising trend in mushroom use among youth and increasing emergency-room visits for psilocybin-induced psychosis. He cautions about the lack of regulation for kratom and its potential to worsen brain function, presenting it as another “weapon of mass destruction” in public health discussions. Towards the end, Amen describes his clinical experiences with trauma, epigenetics, and intergenerational influences on mental health, stressing that thoughts, even disturbing ones, do not define character and can be managed through cognitive strategies such as cognitive behavioral techniques and reframing. He closes with a personal call to care for brain health, emphasizing practical steps like sleep, exercise, nutrition, vitamin D optimization, dental health, reducing toxin exposure, and mindful use of technology, including cautions about AI’s potential impact on cognitive function.

America is ridiculously overmedicated, especially with antidepressants and anxiety drugs, and Britain is following suit. Millions of young people are taking unnecessary, mind-bending drugs for self-diagnosed anxiety and depression. This leads to a generation of isolated, mentally altered individuals, which correlates with issues like mass shootings. We are massively overmedicating young people. Therefore, I support efforts to curb America's reliance on these mind-altering substances.